Financial Management Professionals Inc. Cuts Position in HCA Healthcare, Inc. (NYSE:HCA)

Financial Management Professionals Inc. trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 31.1% in the fourth quarter, Holdings Channel reports. The firm owned 164 shares of the company’s stock after selling 74 shares during the period. Financial Management Professionals Inc.’s holdings in HCA Healthcare were worth $49,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of HCA. American Century Companies Inc. grew its position in HCA Healthcare by 60.0% in the second quarter. American Century Companies Inc. now owns 23,024 shares of the company’s stock valued at $7,397,000 after acquiring an additional 8,633 shares in the last quarter. Renaissance Technologies LLC acquired a new position in HCA Healthcare in the 2nd quarter worth $4,112,000. Blair William & Co. IL grew its stake in shares of HCA Healthcare by 11.8% during the second quarter. Blair William & Co. IL now owns 9,464 shares of the company’s stock valued at $3,041,000 after acquiring an additional 998 shares in the last quarter. Seven Eight Capital LP purchased a new position in HCA Healthcare in the second quarter valued at about $397,000. Finally, Ieq Capital LLC increased its holdings in HCA Healthcare by 32.8% during the 2nd quarter. Ieq Capital LLC now owns 8,408 shares of the company’s stock worth $2,701,000 after purchasing an additional 2,075 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 0.4 %

HCA opened at $310.60 on Monday. The firm’s fifty day moving average price is $316.69 and its two-hundred day moving average price is $353.01. The company has a market capitalization of $78.68 billion, a P/E ratio of 13.95, a P/E/G ratio of 1.03 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $278.50 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were paid a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on HCA shares. KeyCorp cut their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Morgan Stanley reduced their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.